Author

Niklas Selfjord

AstraZeneca (Sweden)ORCID 0009-0008-5628-5849Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:CRISPR screen· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Research Focus:variant calling· 1

Frequent Co-Authors

Anna-Lena Loyd· 2 shared Katja Madeyski-Bengtson· 2 shared Marcello MarescaiD· 2 shared Mike A. Firth· 2 shared Panagiotis AntoniouiD· 2 shared Aikaterini EmmanouilidiiD· 1 shared Alexandra MadseniD· 1 shared Ashley M. JacobiiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersGenomics

Anna-Lena Loyd

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

GenomicsbioRxivPreprintJun 10, 2026

Single-Cell and Tissue-Specific CRISPR Editing Analyses Unveil New Insights to Off-Targets and Translocations

Alexandra Madsen, Niklas Selfjord, Marta Martínez-Lage…·Pınar Akçakaya

The paper analyzes CRISPR-Cas9 off-target mutations and translocations at single-cell and tissue-specific levels in mice, revealing context-dependent variability in editing outcomes.

1 citation

mouseCRISPR screen

𝕏 PostBluesky

BioengineeringbioRxivPreprintFeb 1, 2024

Improved nuclease-based prime editing by DNA repair modulation and pegRNA engineering

Panagiotis Antoniou, Louis C. Dacquay, Niklas Selfjord…·Martin Peterka

This paper improves prime editing by modulating DNA repair pathways and engineering pegRNA, achieving higher precision and efficiency in human and mouse cells.

10 citations

humanmouse

𝕏 PostBluesky